SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
Go back to SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK| SCYNEXIS (NASDAQ: SCYX) | Delayed: 4.45 -0.18 (3.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $7.29 | |||
| Open | $4.58 | 52 Week Low | $1.74 | |||
| Day High | $4.81 | P/E | N/A | |||
| Day Low | $4.42 | EPS | $0.00 | |||
| Volume | 38,015 | |||||
